Search

Your search keyword '"Amiji, MM"' showing total 178 results

Search Constraints

Start Over You searched for: Author "Amiji, MM" Remove constraint Author: "Amiji, MM"
178 results on '"Amiji, MM"'

Search Results

101. Novel RNA interference-based therapies for sepsis.

102. Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer.

103. In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles.

104. Multifunctional nanoparticles for targeting cancer and inflammatory diseases.

106. Role of integrated cancer nanomedicine in overcoming drug resistance.

107. Systemically administered gp100 encoding DNA vaccine for melanoma using water-in-oil-in-water multiple emulsion delivery systems.

108. Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer.

109. Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors.

110. Anti-angiogenic and anti-cancer evaluation of betulin nanoemulsion in chicken chorioallantoic membrane and skin carcinoma in Balb/c mice.

111. Lipid-functionalized dextran nanosystems to overcome multidrug resistance in cancer: a pilot study.

112. Safety assessment of oral photodynamic therapy in rats.

113. Synthesis and preliminary in vivo evaluations of polyurethane microstructures for transdermal drug delivery.

114. Image-guided nanosystems for targeted delivery in cancer therapy.

115. Therapeutic strategies for endothelial dysfunction.

116. 'Click' synthesis of dextran macrostructures for combinatorial-designed self-assembled nanoparticles encapsulating diverse anticancer therapeutics.

117. Photodynamic effects of methylene blue-loaded polymeric nanoparticles on dental plaque bacteria.

118. Mucoadhesive nanomedicines: characterization and modulation of mucoadhesion at the nanoscale.

119. Dual TNF-α/Cyclin D1 Gene Silencing With an Oral Polymeric Microparticle System as a Novel Strategy for the Treatment of Inflammatory Bowel Disease.

121. Nanoparticles: a promising modality in the treatment of sarcomas.

122. Non-viral eNOS gene delivery and transfection with stents for the treatment of restenosis.

123. Development and validation of a rapid reversed-phase HPLC method for the determination of the non-nucleoside reverse transcriptase inhibitor dapivirine from polymeric nanoparticles.

124. Augmentation of therapeutic efficacy in drug-resistant tumor models using ceramide coadministration in temporal-controlled polymer-blend nanoparticle delivery systems.

125. Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma.

126. Brain delivery of proteins by the intranasal route of administration: a comparison of cationic liposomes versus aqueous solution formulations.

127. In vitro and in vivo studies of local arterial gene delivery and transfection using lipopolyplexes-embedded stents.

128. Nanotechnology-based systems for the treatment and prevention of HIV/AIDS.

129. Nanoparticle-based endodontic antimicrobial photodynamic therapy.

130. Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma.

131. Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells.

132. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.

133. A model predicting delivery of saquinavir in nanoparticles to human monocyte/macrophage (Mo/Mac) cells.

134. Multi-functional nanocarriers to overcome tumor drug resistance.

135. Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease.

136. Biodistribution and pharmacokinetic analysis of Paclitaxel and ceramide administered in multifunctional polymer-blend nanoparticles in drug resistant breast cancer model.

137. Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles.

138. Enhanced mucosal and systemic immune response with squalane oil-containing multiple emulsions upon intranasal and oral administration in mice.

139. Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations.

140. Development of novel biodegradable polymeric nanoparticles-in-microsphere formulation for local plasmid DNA delivery in the gastrointestinal tract.

141. Cell Transfection and Analysis Using DNA-Loaded Gelatin Nanoparticles.

142. Preparation and loading of gelatin nanoparticles.

143. Intracellular trafficking studies using gold-encapsulated gelatin nanoparticles.

144. Protein nanospheres for gene delivery.

145. Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer.

146. Role of nanotechnology in pharmaceutical product development.

147. Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery.

148. Synthesis and evaluation of tripodal peptide analogues for cellular delivery of phosphopeptides.

149. Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS).

150. Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer.

Catalog

Books, media, physical & digital resources